Advance Search | Bentham Science

Regulation of Glycolytic and Mitochondrial Metabolism by Ras

Journal: Current Pharmaceutical Biotechnology
Volume: 14 Issue: 3 Year: 2013 Page: 251-260
Author(s): J. Chesney,S. Telang

Selumetinib in Advanced Non Small Cell Lung Cancer (NSCLC) Harbouring KRAS Mutation: Endless Clinical Challenge to KRAS-mutant NSCLC.

Journal: Reviews on Recent Clinical Trials
Volume: 8 Issue: 2 Year: 2013 Page: 93-100
Author(s): Paolo Maione,Assunta Sgambato,Antonio Rossi,Paola Claudia Sacco,Maria Anna Bareschino,Clorinda Schettino,Francesca Casaluce,Fortunato Ciardiello,Cesare Gridelli

Identifying Coevolution Between Amino Acid Residues in Protein Families: Advances in the Improvement and Evaluation of Correlated Mutation Algorithms

Journal: Current Bioinformatics
Volume: 8 Issue: 2 Year: 2013 Page: 148-160
Author(s): Haisong Xu,Xiaoqin Li,Ziding Zhang,Jiangning Song

Applied Computational Techniques on Schizophrenia Using Genetic Mutations

Journal: Current Topics in Medicinal Chemistry
Volume: 13 Issue: 5 Year: 2013 Page: 675-684
Author(s): Vanessa Aguiar-Pulido, Marcos Gestal, Carlos Fernandez-Lozano, Daniel Rivero, Cristian R. Munteanu

Nucleotide Binding Affects Intrinsic Dynamics and Structural Communication in Ras GTPases

Journal: Current Pharmaceutical Design
Volume: 19 Issue: 2 Year: 2013 Page: 4214-4225
Author(s): Francesca Fanelli, Francesco Raimondi

Treatment Directed to Signalling Molecules in Patients with Advanced Differentiated Thyroid Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13 Issue: 3 Year: 2013 Page: 483-495
Author(s): Jose M.G. Saez

Gene Polymorphism of Angiotensin II Type 1 and Type 2 Receptors

Journal: Current Pharmaceutical Design
Volume: 19 Issue: 1 Year: 2013 Page: 2996-3001
Author(s): Tomohiro Katsuya, Ryuichi Morishita

Personalized Medicine for Glioblastoma: Current Challenges and Future Opportunities

Journal: Current Molecular Medicine
Volume: 13 Issue: 3 Year: 2013 Page: 358-367
Author(s): J.-J. Zhu,E. T. Wong

The Renin-angiotensin System as a Target of Novel Anticancer Therapy

Journal: Current Pharmaceutical Design
Volume: 19 Issue: 4 Year: 2013 Page: 7103-7125
Author(s): Katarzyna Regulska, Beata Stanisz, Milosz Regulski

Molecular Mechanisms and Modulation of Key Pathways Underlying the Synergistic Interaction of Sorafenib with Erlotinib in Non-Small-Cell-Lung Cancer (NSCLC) Cells

Journal: Current Pharmaceutical Design
Volume: 19 Issue: 5 Year: 2013 Page: 927-939
Author(s): E. Giovannetti,M. Labots,H. Dekker,E. Galvani,J.S.W. Lind,R. Sciarrillo,R. Honeywell,E.F. Smit,H.M. Verheul,G.J. Peters

Search

Find Journals, Volumes, Issues, Articles, Ebooks and Chapters

Search Result "RAS mutations"